MAPT and Alzheimer disease: In investigating its functional link to AD, APOE4 has been associated with, though not limited to, the following: impaired utilization of glucose in the CNS, blood–brain barrier (BBB) breakdown, increased levels of intracellular Aβ, and the phosphorylation of tau proteins [5,12,13].